Dopaminergic mechanisms have been implicated in the pathogenesis of schizophrenia.' Psychosis induced by the dopamine-receptor agonist bromocriptine has been described mainly with high-dose regimens in Parkinsonism and less frequently with the lower doses used in hormonal disorders.24 The following case is of interest because of the insidious onset of psychosis and the family history of paranoid schizophrenia.
Comment
This psychotic episode appears to have been precipitated by bromocriptine. There Acromegaly was diagnosed on the basis of a five-year history of enlargement of the face, hands, and feet and grossly raised growth hormone concentrations (table) . Skull radiography showed an enlarged pituitary fossa with destruction of the posterior wall and floor. Computed tomography showed asymmetry of the sella floor and right-sided destruction but no appreciable suprasellar or extrasellar tumour extension. Visual fields were normal. An excision biopsy specimen of the breast lump showed duct ectasia with some "lactational" change.
Bromocriptine 2-5 mg daily was started on 28 January 1982, increasing to 10 mg over the next two weeks and to 30 mg over the following month; this was continued until his admission in a psychotic state on 30 April. In retrospect, two weeks after starting bromocriptine he had become totally absorbed in his music, believing that it had a unique, inexpressible "threedimensional" quality. His musical ideas became more bizarre and complex over the next 10 weeks and he spent long periods in bed engrossed in their interrelated meanings. Ten days before admission he had a vivid dream of a mother with a child with Down's syndrome, which he took to be a direct experience of God. He became preoccupied with ideas of good and evil and increasingly frightened. This led to a delusional misinterpretation that the devil was outside their home, and he and his wife fled to relatives. They began to suspect that his disturbance was due to the bromocriptine, which he discontinued, and they came to the casualty department. Up to this point his wife had shared his ideas, but this changed when he stated that she was evil and absconded with their child from casualty. He returned within hours, was admitted to a medical ward, and was later transferred to the psychiatric unit.
On admission he was in a fearful, paranoid, agitated state, showing partial insight in the presence of clear consciousness and absence of overt mood disorder, hallucinations, passivity phenomena, or formal thought disorder. On treatment with thioridazine 250 mg daily his paranoid ideas disappeared within a week. He was discharged taking trifluoperazine, which he failed to continue, and was readmitted two weeks later, for 10 days, with a mild recurrence of paranoid ideation that responded to trifluoperazine 10 mg daily. This was tailed off over a month with no recurrence of psychotic symptoms. Subsequent pituitary surgery was planned.
Treatment of digoxin overdose with antigen-binding fragments of digoxin-specific antibodies Severe digoxin toxicity due to accidental or deliberate overdose is rare, but is often life-threatening, especially if there is pre-existing cardiac disease. Treatment with gastric lavage, adjustment of electrolyte balance, antiarrhythmic drugs, pacing, and, when necessary, lowvoltage DC shock is not always effective and the ultimate aim must be to lower circulating free digoxin concentrations. Dialysis and haemoperfusion clear digoxin but blood concentrations are rapidly restored from the large extravascular pool.' We treated a patient with severe digoxin toxicity using digoxin-specific antibodies and we report the efficacy of this treatment in a potentially lethal condition.
Case report
A 60-year-old man with a history of left ventricular failure, mitral regurgitation, and intermittent atrial fibrillation treated with digoxin, diuretics, and warfarin, was admitted after a suicide attempt with 12*5 mg digoxin, 150 mg warfarin, and 40 mg diazepam. On examination he was alert, in sinus rhythm at 60 beats/min, and blood pressure was 110/60 mm Hg. He was not in overt heart failure and cardiac signs were unchanged. Electrolyte balance and cardiac enzyme activities were normal. Chest x-ray film showed an enlarged heart. There was complete left bundle-branch block and left axis deviation on the electrocardiogram as previously, but the P-R interval was now prolonged to 0-28 seconds and there were frequent ventricular ectopics, some of which were multiple and multifocal. The initial serum digoxin concentration was 13 g/l (therapeutic range up to 2-2 g/l) and prothrombin index 7-9. Gastric lavage was carried out one and a quarter hours after the overdose.
A lignocaine infusion was started and a prophylactic temporary transvenous pacemaker inserted. Potassium concentrations were closely controlled. Despite these measures bradycardia worsened and the electrocardiographic changes persisted. We decided to lower the digoxin concentrations with antigen-binding fragments of sheep digoxin antibody. After preliminary test
